HIV/AIDS Biomedical and Clinical Research

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with Unit

Memorial Deadline: Thursday 1st, November 2018

External Deadline: Tuesday 6th, November 2018


Description

Under the Federal Initiative to Address HIV/AIDS, CIHR has, over the past years, funded biomedical and clinical research with both small pilot project funding opportunities and very large team grants. While there are trends towards funding HIV, Hepatitis C and other STBBIs in a more coordinated fashion, this funding opportunity will focus solely on HIV,  seeking to ensure that focused teams (that may work in areas of higher risk) as well as large more expansive teams (that will bring together experts from different disciplines working collaboratively on a number of inter-related research projects under a unified program of research) have the opportunity to extend their innovative research and training efforts.

To ensure that large teams are well positioned not only to generate important new knowledge but to also apply it in timely fashion, their programs must include a strong core of basic scientists and clinical investigators. These teams must discuss training plans in order to build further capacity for HIV research and stimulate innovative approaches. They must also consider the relevance of their work to people living with HIV and the ethical implications of this work and, therefore, must include relevant stakeholders in the oversight of the program of research.

CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

  • The total amount available for this funding opportunity is $20,000,000, enough to fund approximately 6 grants. This amount may increase if additional funding partners participate.
  • Of this $20,000,000:
    • $8,000,000 is available for focused team grants:
      • $4,000,000 is available to fund applications relevant to the From Control to Cure (CURE) research area, enough to fund 2 grants.
      • $4,000,000 is available to fund applications relevant to the Biomedical Prevention research area, enough to fund 2 grants.
      • The maximum amount per grant is $400,000 per year for up to five years for a total of $2,000,000.
    • $12,000,000 is available for the large team grants:
      • $6,000,000 is available to fund applications relevant to the From Control to Cure (CURE) research area, enough to fund 1 grant.
      • $6,000,000 is available to fund applications relevant to the Biomedical Prevention research area, enough to fund 1 grant.
      • The maximum amount per grant is $1,200,000 per year for up to five years for a total of $6,000,000.

For additional details, visit CIHR’s website.


Funding Sources

Canadian Institute of Health Research (CIHR)



This opportunity was posted by: RGCS

Last modified: June 1, 2018